Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  1. Tolaney, S.M.
  2. Guarneri, V.
  3. Seo, J.H.
  4. Cruz, J.
  5. Abreu, M.H.
  6. Takahashi, M.
  7. Barrios, C.
  8. McIntyre, K.
  9. Wei, R.
  10. Munoz, M.
  11. Antonio, B.S.
  12. Liepa, A.M.
  13. Martin, M.
  14. Johnston, S.R.D.
  15. Kellokumpu-Lehtinen, P.-L.
  16. Harbeck, N.
Revue:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Année de publication: 2024

Volumen: 199

Type: Article

DOI: 10.1016/J.EJCA.2024.113555 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus